DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY 2025 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.800-2.000 for the period, compared to the consensus EPS estimate of 1.910. The company issued revenue guidance of $3.5 billion-$3.6 billion, compared to the consensus revenue estimate of $3.7 billion.

DENTSPLY SIRONA Stock Down 8.8 %

XRAY traded down $1.66 during trading on Thursday, hitting $17.15. 6,160,723 shares of the company’s stock were exchanged, compared to its average volume of 2,461,708. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $18.90 and its two-hundred day moving average is $21.58. DENTSPLY SIRONA has a fifty-two week low of $17.09 and a fifty-two week high of $34.91. The stock has a market cap of $3.41 billion, a P/E ratio of -8.28, a PEG ratio of 1.80 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.21). DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. As a group, equities analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.73%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several recent analyst reports. Mizuho initiated coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. Morgan Stanley reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $24.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.